严重低血糖与2型糖尿病个体特定原因死亡的绝对风险:一项英国初级保健观察性研究
基于英国临床实践研究数据链中1998年1月1日至2011年1月1日诊断的2型糖尿病成人队列,纳入74,610人,其中388人(0.5%)曾因严重低血糖住院。中位随访7.1年,校正混杂因素并考虑竞争风险后,严重低血糖者的5年心血管死亡绝对风险为6.6%、癌症为1.1%、其他原因为13.1%。作者认为严重低血糖更可能是长期死亡风险升高的标志而非因果因素。
要点
- 388人(0.5%)曾因严重低血糖住院,该组年龄更大、HbA1c更高、多病共存更普遍。
- 60岁严重低血糖者5年绝对风险:心血管6.6%、癌症1.1%、其他原因13.1%。
- 与非严重低血糖者相比,5年绝对风险差:心血管4.7%、癌症-1.4%、其他原因11.1%。
核心结论
- 作者认为严重低血糖是长期死亡风险升高的标志而非因果关联,但严重低血糖发作是2型糖尿病患者强烈的负性预后因素。
研究设计与样本
- 英国初级保健观察性研究,基于英国临床实践研究数据链数据库,纳入1998年1月1日至2011年1月1日诊断的2型糖尿病成人现患队列,并与国家统计局(ONS)和医院统计数据库(HES)链接。
- 队列共纳入74,610人,其中388人(0.5%)在索引日期前至少一次因严重低血糖住院。
- 分析量化有无严重低血糖住院者的5年特定原因死亡风险,校正潜在混杂因素并考虑竞争风险。
主要发现
- 中位随访7.1年,有严重低血糖者死亡236例(60.8%),无严重低血糖者死亡18,539例(25.0%)。
- 两组中非心血管原因均占全部死亡的71%。
- 60岁严重低血糖者校正年龄、性别、族裔、收缩压、总胆固醇、HbA1c、BMI、eGFR、吸烟状态、饮酒量和贫困指数(Townsend评分)后,5年绝对死亡风险为心血管6.6%、癌症1.1%、其他原因13.1%。
- 与非严重低血糖者相比的5年绝对风险差:心血管4.7%(95%CI 1.0, 8.3)、癌症-1.4%(95%CI -4.1, 1.4)、其他原因11.1%(95%CI 6.1, 16.1)。
- 进一步校正药物和合并症(心肌梗死、卒中、外周动脉疾病、心力衰竭、心房颤动、癌症)后结果一致,磺脲类和胰岛素与死亡率升高相关,特定原因风险比从磺脲类使用与癌症死亡的1.06(95%CI 0.99, 1.14)到胰岛素使用与心血管死亡的1.42(95%CI 1.29, 1.56)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Several pathophysiological mechanisms would suggest a causal link between hypoglycaemia and cardiovascular death; conversely, current knowledge would not support a causal relationship with other causes of death. To clarify the nature and the magnitude of the association between hypoglycaemia and death, we investigated the 5 year mortality risks for cardiovascular disease, cancer and other causes in individuals with type 2 diabetes admitted to hospital for a severe hypoglycaemic episode. METHODS: We defined in the UK Clinical Practice Research Datalink database a prevalent cohort of adults with type 2 diabetes diagnosed between 1 January 1998 and 1 January 2011 (index date), with available linkage to the Office for National Statistics (ONS) and the Hospital Episode Statistics (HES). A hospital admission reporting hypoglycaemia as the underlying cause was identified before the index date in the HES; date and underlying cause of death were obtained from the ONS. We quantified the 5 year risk of cause-specific death in people with and without admission to hospital for severe hypoglycaemia, adjusting for potential confounders and accounting for competing risk. RESULTS: Of the 74,610 subjects included in the cohort, 388 (0.5%) were admitted at least once for a severe hypoglycaemic episode; subjects admitted were older, with higher HbA1c and a greater prevalence of multimorbidity. During a median follow-up of 7.1 years, 236 (60.8%) and 18,539 (25.0%) deaths occurred in subjects with and without a previous severe hypoglycaemia, respectively. Non-cardiovascular causes accounted for 71% of all deaths in both subjects with and without hypoglycaemia. In a 60-year-old person with severe hypoglycaemia, the 5 year absolute risk of death, adjusted for age, sex, ethnicity, systolic blood pressure, total cholesterol, HbA1c, BMI, eGFR, smoking status, alcohol consumption and deprivation (Townsend score), was 6.6%, 1.1% and 13.1% for cardiovascular, cancer and other causes, respectively, while the 5 year absolute risk difference compared with a subject without severe hypoglycaemia was 4.7% (95% CI 1.0, 8.3) for cardiovascular, -1.4% (-4.1, 1.4) for cancer and 11.1% (6.1, 16.1) for other causes of death. Results were consistent in models further adjusted for medications and comorbidities (myocardial infarction, stroke, peripheral artery disease, heart failure, atrial fibrillation, cancer), with sulfonylurea and insulin associated with increased mortality rates (from cause-specific hazard ratio of 1.06 [95% CI 0.99, 1.14] for cancer death with use of sulfonylurea to 1.42 [1.29, 1.56] for cardiovascular death with use of insulin). Results were robust to missing data. CONCLUSIONS/INTERPRETATION: The results of this study indicate severe hypoglycaemia as a marker of, rather than causally linked to, an increased risk of long-term mortality. Regardless of the nature of the association, a severe hypoglycaemic episode represents a strong negative prognostic factor in patients with type 2 diabetes. Graphical abstract.
引用
- Zaccardi F, Ling S, Lawson C, et al. Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study. Diabetologia. 2020. PMID: 32728893. doi:10.1007/s00125-020-05223-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。